患者中年男性，主因“间断胸闷气促8年，加重1月”入院。 临床诊断为：全心衰竭；扩张性心肌病；心脏扩大；二尖瓣中度关闭不全；三尖瓣中度关闭不全；心功能IV级（NYHA分级）；INTERMACS3级；高血压病2级很高危；2型糖尿病；心律失常，房性早搏，房性心动过 ...

本研究针对老年2型心肌梗死(MI)患者预后评估难题，通过分析3007例80岁以上患者的NT-proBNP水平动态变化，首次证实NT-proBNP变化>10%增加与心衰(HF)发生及全因死亡率显著相关。该发现为老年2型MI患者的风险分层提供了新的生物标志物监测策略，对指导个体化治疗具有 ...

心力衰竭（HF）影响了高达40%的2型糖尿病（T2DM）患者，给临床和经济带来了巨大负担。N端B型利钠肽前体（NT-proBNP）能有效评估HF风险，但其在中国的经济价值尚不明确。 方法 本研究评估了三种HF风险评估策略在T2DM患者中的成本效益：基于NT-proBNP的评估（临界值 ...

心脏是给血液循环的动力来源。而心力衰竭(heart failure, ...

Measuring N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels preoperatively among patients scheduled to undergo inpatient noncardiac surgery can strongly predict the risk of major cardiac ...

In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...

Please provide your email address to receive an email when new articles are posted on . NT-proBNP may predict CV death, incident HF and fatal or nonfatal CV events after acute MI. The association was ...

In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...

Elevated levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP), a key biomarker for diagnosing heart failure, show a nearly fourfold increased risk for atrial fibrillation (AF) in at-risk ...

Please provide your email address to receive an email when new articles are posted on . Baseline N-terminal pro-B natriuretic peptide in patients with HF with preserved ejection fraction accurately ...